Product Images Drospirenone/ethinyl Estradiol/levomefolate Calcium And Levomefolate Calcium

This text provides ranges of the number of women with a blood clot per 10,000 women years, categorized by Non-Pregnant and Postpartum stages and usage of combined oral contraceptives. The Non-Pregnant stage is further divided into Non-COC users and COC users. Actual duration of pregnancy in the reference studies was used for determining the clotting rate during Pregnancy. The number of women with a blood clot is represented on the y-axis and the associated ranges are represented on the x-axis.*

This appears to be descriptions of different methods of birth control, including the number of pregnancies per 100 women using each method. It lists various types of birth control such as injections, intrauterine devices, sterilization, birth control pills, and condoms. Additionally, it lists the effectiveness of certain methods for preventing pregnancy such as avoiding sex during the most fertile days of the monthly cycle and using spermicide. However, did not successfully capture all parts of the text, so some information may be missing.*

This appears to be a chart displaying different ranges for blood clot risk in non-pregnant women who either use or do not use COC (contraceptive pills), pregnant women, and women in the postpartum period (up to 12 weeks after birth). The numbers indicate the number of women out of 10,000 women years (WY) who experienced a blood clot. The pregnancy data is based on the actual duration of pregnancy in reference studies, with an assumption that the pregnancy takes nine months. The rate given is 7 to 27 per 10,000 WY.*

This is a graph illustrating RBC folate levels in a group of 75 participants taking Yasmin with levomefolate calcium over the course of 44 weeks. The graph shows the baseline folate levels at the beginning of the study, followed by a decrease during the elimination phase, and then an increase during the treatment phase with time. The x-axis represents the 44-week timeline, and the y-axis represents the folate concentration measured in nm.*

This is a graph showing the levels of plasma folates measured in nmol/L over time (in weeks) for a group of 75 people. The graph includes three phases: baseline, treatment, and elimination. During the treatment phase, the group was given a combination of vasmin and levomefolate calcium. The graph shows that the plasma folate levels increased during treatment and decreased during the elimination phase.*

This is a list of relevant studies related to breast cancer risk associated with the use of combined oral contraceptives. The studies include the NICHD Women's Care Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses’ Health Study II, Oxford Family Planning Study, and Danish Sex Hormone Register Study. Some of these studies compare breast cancer risk between women who have ever used COC versus those who have never used it, while others compare breast cancer risk between current COC users and those who have never used it. The table at the end provides effect estimates of the risk, such as odds ratio, relative risk, and hazard ratio, from some of the studies.*